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Examination of samples of stool from a 61-year-old male patient, presenting with the 
clinical symptoms of Crohn’s disease (CD), revealed massive shedding of acid fast bacilli 
with the morphology of Mycobacterium avium paratuberculosis (MAP), the causative 
agent of Johne’s disease in cattle. MAP was cultured from the stool. Biotyping of the 
bacterium isolated from cultures of stool demonstrated, it was the Indian Bison biotype 
of MAP, the dominant biotype infecting livestock and humans in India. Based on this 
finding and because the patient was unresponsive to standard therapy used in India 
to treat patients with gastrointestinal inflammatory disorders, the patient was placed 
on a regimen of multi-antibiotic therapy, currently used to treat tuberculosis and CD. 
After 1 year of treatment, the patient’s health was restored, concurrent with cessation 
of shedding of MAP in his stool. This patient is the first case shown to shed MAP from 
the stool who was cured of infection with antibiotics and who was concurrently cured of 
clinical signs of CD.
Keywords: Mycobacterium avium paratuberculosis, Crohn’s disease, antibiotic therapy, stool culture and 
microscopy for MAP, eLIsa, Is900 pCR and Is1311 pCR_Re
INtRoDUCtIoN
A major question that has remained unanswered over the past years is whether Mycobacterium 
avium paratuberculosis (MAP), the causative agent of Johne’s disease in cattle, is zoonotic and also the 
causative agent of Crohn’s disease (CD). The lack of resolution of this question is partly attributable 
to the difficulty of demonstrating the presence of MAP in all patients with the clinical symptoms of 
CD and the finding of MAP in patients with other gastrointestinal disorders as well as other diseases 
and also in humans with no signs of disease. The case report presented here, and results from an 
extensive survey we recently conducted in India, have provided an explanation for why it has been 
difficult to show MAP is the causative agent of CD in, at least, a subset of patients with CD. The survey 
of 42,400 subjects revealed humans like other species are equally susceptible to infection with MAP 
regardless of health status (1). We detected the presence of MAP in subjects with no clinical signs of 
disease and subjects with disorders involving the skin, liver, abdomen, gastrointestinal tract, thyroid, 
FIgURe 1 | Representative picture showing results from three 
independent endoscopic evaluations of the intestine of the patient 
obtained at different times before he was started on antibiotic 
therapy. There was no opportunity for further evaluations during treatment.
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blood (anemia), pancreas (diabetes), autoimmune inflammatory 
disorders, and infectious diseases, e.g., tuberculosis, typhoid, and 
malaria. The survey also revealed very few of subjects infected 
with MAP had detectable cocco-bacilli in their stool, as detected 
by microscopy, including subjects with overt clinical signs of CD, 
similar to an earlier study (2). The subjects identified in these 
studies were poor, and there was no opportunity to arrange 
for treatment, leaving open the question of whether antibiotic 
therapy could be used to cure infection with MAP and whether a 
cure would also affect a cure of CD. The subject of this case report 
has provided an opportunity to answer both questions.
Case RepoRt
A 61-year-old male, a resident of a rural village of Rajasthan 
state in India, had a history of frequent bowel movements with 
passage of loose stool or mucus every half hour. He had lost 
weight and was emotionally distressed by the lack of the medical 
community’s ability to obtain a diagnosis and treatment for his 
illness. The patient was referred to us at the Central Institute for 
Goat Research (CIRG) approximately 3 years ago by his relative, 
a veterinary officer in the State Animal Husbandry Department 
of Rajasthan state. The officer was familiar with the screening of 
animals for MAP infection in goats, sheep, cattle, and buffaloes 
and knew of the reported association of MAP with CD. On the 
initial visit, the patient suffered from severe depression in addi-
tion to presenting with the clinical signs and symptoms of diar-
rhea, weakness, weight loss, fatigue, and anorexia, symptoms that 
closely resemble the clinical symptoms of Johne’s disease in cattle, 
except for anorexia [reviewed in Ref. (3)]. At the clinical stage of 
Johne’s disease, there is extensive infiltration of the mucosa with 
MAP infected macrophages and lymphocytes, associated with a 
loss in the integrity of the absorptive epithelium, resulting weight 
loss, and constant diarrhea. Bacteria are readily identified in feces 
at this late stage of disease [reviewed in Ref. (3)]. The patient was 
desperate and turned to the CIRG as a last resort. The patient had 
consulted with gastroenterologists over the previous years and 
sought care in hospitals in Bharatpur and New Delhi (Aakash 
Medical Center, Sir Ganga Ram Hospital and All India Institute 
of Medical Sciences) for the treatment of his ailment. Several 
endoscopic evaluations conducted during the visits to hospitals 
demonstrated the presence of inflammation in the intestine 
(Figure 1); however, the gastroenterologists did not include CD 
as one of the possible reasons for inflammation. Biopsies were not 
taken for evaluation. The patient was treated with the standard 
therapy for Irritable bowel diarrhea (IBD), steroids, and azathio-
prine. Treatment provided no improvement.
Serum, blood, and stool were collected to check for the presence 
of MAP infection, using the four diagnostic tests [microscopy, 
culture, IS900 PCR (stool and blood), and ELISA] used in the 
survey (1, 4). The general procedure for isolating MAP for culture 
and examination by microscopy in our laboratory proved to be 
exceptionally important with this case. The procedure for screen-
ing for the presence of MAP in fecal samples (2) is included in this 
report so that this procedure may be used by other laboratories. 
Approximately 2 g of stool were placed in 12 ml of sterilized water 
and finely minced using a pestle and mortar under sterilized 
conditions. The mixture was then centrifuged at 4,500  rpm at 
room temperature for 45  min. The supernatant was discarded, 
leaving a pellet, comprised of a dense layer of solid material at 
the bottom and a thin layer of semisolid less dense material at 
the top. Two sterile swabs were used to collect material from 
the semisolid upper layer, one to make a slide and the second to 
prepare a culture. The latter swab was placed in a tube contain-
ing 40 ml of a 0.9% hexadecyl pyridinium chloride in water to 
decontaminate fecal material. The mixture was allowed to stand 
for 18  h at room temperature. The supernatant was decanted 
and 0.2  ml of the residual sediment inoculated onto slants of 
Herrold’s egg yolk medium (three containing mycobactin J and 
one without mycobactin J). Microscopic examination of the stool 
specimen revealed the patient was shedding massive numbers of 
acid fast short rods (cocco-bacilli) (+3 to +4), with morphology 
indistinguishable from MAP (Figure 2A). Following 5 months of 
culture of stool, small colonies of bacteria were detected in agar 
slants containing mycobactin J. Biotyping of the colonies with the 
IS1311 PCR_RE and IS1311 L2 PCR_REA (5, 6) demonstrated 
the bacterium was the “Indian Bison type,” of MAP, the prevalent 
form of MAP in India (4). The patient’s serum was positive for 
MAP by ELISA.
tReatMeNt
After our report to the patient, the patient went to New Delhi to 
the All India Institute of Medical Sciences, which is one of the 
best institutions in Medicine in India. He met with the Head of 
the Division of Gastroenterology for treatment. The gastroen-
terologist believed the patient had IBD and treated him accord-
ingly with the standard treatment for IBD. Following 15  days 
of treatment, there was no improvement in the patient’s failing 
condition and he returned to the CIRG very depressed. He was 
losing weight with the frequency of bowel movements every half 
hour. He requested the CIRG provide him with an injection of 
institute’s vaccine that was shown to have a therapeutic effect. 
He was informed that this was not possible. As an alternative, 
FIgURe 3 | Biotyping of “Indian Bison type” MAP bacilli, by IS 1311 
pCR_Rea, from colonies developed at the end of 12 months of 
culture on HeY medium, columns 4 and 5.
taBLe 1 | summary of treatment regimen up to 12 months.
Drug categories type of medicine treatment duration
Antibiotics Levofloxacin (750 mg) 1–11 weeks
Clarithromycin (250 mg) 9–38 weeks
Isoniazid (300 mg) Up to 13 weeks
Rifampicin (450 mg) Up to 13 weeks
Ethambutol (800 mg) Up to 13 weeks
Rifaximin (550 mg) 7–18 weeks
Rifabutin (150 mg) 11–42 weeks
Anti-inflammatory Mesalazine or  
5-aminosalicylic acid
1–38 weeks (1 g) and up 
to 48 weeks (2 g)FIgURe 2 | (a) Heavy shedding of typical MAP bacilli as seen in ZN staining: 
4+ (positive). (B) Negative for MAP bacilli at the end of 12 months of 
treatment.
taBLe 2 | screening of clinical samples (feces, blood, and serum) by 
multiple diagnostic tests for the presence of MAP infection at different 
days post-treatment.
tests 0th day 120 days 360 days
1. ELISA kit – seruma
a. OD values 0.3255 0.7186 0.5826
b. Status of MAP Negative Positive Positive
2. Microscopy – stool +3 to +4 +2 to +1 Negative
3. Culture – stoolb Multi-bacillary Pauci-billary Negative
4. IS900 PCR-blood and stoolc Negative Negative Negative
aStatus of MAP infection as per S/P ratio (8) using “Indigenous ELISA kit.”
bMAP colonies took 1 year to grow.
cFrom DNA isolated directly from blood and stool samples.
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we at CIRG arranged for consultation with a local physician and 
coauthor, Dr. Prabhat Agarwal, an Assistant Professor at the S.N. 
Medical College, Agra, with a small clinic in Farah where CIRG 
is located. Dr. Prabhat Agarwal took interest in the case and 
was willing to consider the patient’s illness could be associated 
with an extensive infection with MAP. Dr. T. J. Borody, who had 
reported success in treating patients with CD with antibiotics 
was contacted for advice and recommendation on how to treat 
the patient (7). Dr. Borody provided copies of recent publica-
tions and suggested what antibiotics should be considered for 
treatment. Based on his suggestions, a regimen of therapy was 
designed and implemented. The patient was informed that his 
clinical symptoms were most likely caused by a MAP infection 
and that a regimen of antibiotic therapy might provide a cure. 
After obtaining his written consent, he was placed on anti-MAP 
therapy under the supervision of Dr. Prabhat Agarwal. The anti-
biotic therapy included clarithromycin, rifampin, ethambutol, 
levofloxacin, isoniazid, and rifaximin along with mesalazine 
according to the schedule in Table 1.
ResULts
After 4 months of treatment, the patient exhibited improvement 
in his physical condition, reduction in stool frequency (two 
to three times a day from every half hour), and improvement 
in appetite. During the last months of treatment, the patient 
experienced continued improvement, with an increase in weight 
and further reduction in stool frequency (one to two times a 
day). Recovery from infection was complete following a year of 
treatment with no signs or symptoms of disease. The follow-up 
stool microscopy was negative for MAP (Figure  2B) and the 
follow-up post-treatment stool culture was negative for MAP. As 
mentioned, biotyping of colonies from cultures of stool showed 
the bacilli were the “Indian Bison type” of MAP (Figure 3). The 
ELISA was positive for MAP also, further confirmation that the 
patient had been infected with MAP (Table 2). The patient is now 
being monitored every 6 months for recurrence of infection and 
general health.
DIsCUssIoN
Recent studies have shown that humans like other species 
are  susceptible to infection with MAP. The first evidence 
of susceptibility was obtained in studies demonstrating the 
presence of MAP in healthy subjects and patients with various 
diseases used as controls in the study of CD (2, 9–16). Most 
of these studies involved examination of small numbers of 
individuals, at a time when it was technically difficult to isolate 
MAP from tissues and fecal samples. Because it was thought that 
MAP is not pathogenic for humans, patients were not routinely 
4Singh et al. Crohn’s Disease and Mycobacterium avium paratuberculosis
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tested for an infection with MAP. Our recent extensive survey 
of 42,400 individuals for the presence of MAP, across the social 
spectrum of populations living in India, a country where there 
is a high prevalence of MAP in domestic and wild animals, the 
food supply and environment, has documented that humans, 
regardless of health status and position in society, can be infected 
with MAP (1, 17–19).
Genomic studies documented that animals and humans were 
infected with a single biotype, the Bison biotype, the most preva-
lent biotype in India, with a signatory short single repeat (SSR), 
7g4ggt, also found in the first isolates of MAP from humans in the 
United States of America (20). In addition to healthy subjects, the 
survey included patients with various illnesses, especially patients 
with intestinal disorders including CD (1, 2). Assays developed to 
test for infection in domestic animals were used to screen subjects 
for the presence of MAP (21). The microscopic assay of fecal 
samples was the most expedient way to identify subjects clearly 
shedding bacteria indistinguishable from MAP. In contrast to 
other studies, bacteria indistinguishable from MAP were detected 
in fecal samples of some patients with the clinical symptoms of 
CD. Follow-up assays with ELISA, culture, PCR with IS900, and 
biotyping of MAP colonies, using the IS1311 PCR_REA and 
IS1311 L2 PCR_REA method (5, 22), documented the isolates 
were the Indian Bison biotype of MAP (21, 23, 24). The survey 
also revealed that the bacterial load in stool was too low to be 
routinely detected by microscopy but could be detected by stool 
culture and specificity documented by IS900 PCR. A similar 
finding has been reported by a group of investigators in Italy (16).
The patient described in this report was from a small village 
in a rural region of Rajasthan state. Although it is not known 
how he became infected, MAP is endemic in livestock and the 
environment in this region. In this setting, exposure of the entire 
population could be from the contaminated environment, direct 
contact with livestock, or from the consumption of milk or milk 
products. Farmer families in India maintain a close contact with 
the domestic livestock, especially milking cattle, buffaloes, and 
goats, and often share living space with animals due to limited 
socioeconomic conditions. Studies on the bio-burden and 
biotyping of MAP infection in large populations of domestic 
livestock, wild ruminants, and other animals in the past 29 years 
have shown that MAP is widely prevalent and endemic in the 
domestic livestock population of the country (4, 19). In addi-
tion, as mentioned previously, mass screening of the human 
population in this part of India revealed a high level (>30.0%) 
of infection with MAP (1). Screening of milk and milk products 
also revealed a high bio-presence of MAP (18). Biotyping of 
MAP strains has consistently shown the presence of the domi-
nant Indian Bison biotype as the most prevalent biotype of MAP 
detected in humans (4, 19).
As stated previously, one of the reasons why it has been so 
difficult to establish that MAP is the causative agent of CD in, 
at least, a subset of patients with CD has been that MAP has 
not been isolated from all patients. Also, the potential remains 
that more than one disease presents with the clinical features 
of CD. A recent study by Chiodini et al. has reported that, “CD 
may be differentiated into 2 distinct biotypes, based on the 
detection of bacterial genomic sequences and virulence genes 
within submucosal tissues” (25). This case provides additional 
evidence, supporting studies showing MAP is the causative agent 
in, at least, a subset of patients with CD (26) and that antibiotic 
therapy may lead to a cure of CD and clearance of infection with 
MAP. The results are consistent with findings from a group of 
MAP infected patients treated successfully by one of the coau-
thors, Dr. J. Todd Kuenstner, in the United States using a regimen 
of multi-antibiotic therapy combined with ultraviolet blood 
irradiation (UVBI) (27, 28). Of major importance, the results 
obtained in this report and the mass survey in India emphasize 
the need for recognition, at the international level, that MAP is 
a zoonotic pathogen and that it is a health risk for humans and 
livestock (29).
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